Search results
Results from the WOW.Com Content Network
The authors came to the conclusion that no further trials of hydroxychloroquine or chloroquine for treatment of COVID-19 should be carried out. [58] On 26 April 2021, in its amended clinical management protocol for COVID-19, the Indian Ministry of Health lists hydroxychloroquine for use in patients during the early course of the disease. [23]
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
In March 2020, then US President Donald Trump promoted the use of chloroquine and hydroxychloroquine, two related anti-malarial drugs, for treating COVID-19. The FDA later clarified that it has not approved any therapeutics or drugs to treat COVID-19, but that studies were underway to see if chloroquine could be effective in treatment of COVID-19.
Hydroxychloroquine has also been linked to serious side effects, including cardiac arrest, heart rhythm issues, liver failure, and kidney disorders, as noted by a 2020 FDA warning about the drug's ...
The book accuses American public health leader Anthony Fauci of 30 years of abuse of power, during both the HIV epidemic and the COVID-19 pandemic. [12]In the book, Kennedy accuses Fauci of pulling off "a historic coup d’état against Western democracy" [13] and promotes unproven COVID-19 treatments, including hydroxychloroquine and ivermectin. [14]
In the first major study comparing hydroxychloroquine to a placebo to gauge its effect against the new coronavirus, University of Minnesota researchers tested 821 people who had recently been ...
On March 28, the FDA issued an Emergency Use Authorization (EUA) which allowed certain hospitalized COVID-19 patients to be treated with hydroxychloroquine or chloroquine. [ 25 ] [ 22 ] [ 26 ] [ 27 ] On June 15, the FDA revoked the EUA for hydroxychloroquine and chloroquine as potential treatments for COVID-19.
On March 28, the FDA issued an Emergency Use Authorization (EUA) which allowed certain hospitalized COVID-19 patients to be treated with hydroxychloroquine or chloroquine. [ 42 ] [ 41 ] [ 43 ] [ 44 ] The FDA's emergency approval was limited to use in hospitals and clinical drug trials.